Prospective real world data of an ongoing post-authorization safety study on idelalisib in patients with CLL and refractory FL M. Hoechstetter, W. Knauf, P. Eissmann, N. Hucke, van A. Troostenburg,H. Ramroth, M. RummelONCOLOGY RESEARCH AND TREATMENT（2018）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
